Skip to main content
. 2017 Feb 12;12:58–69. doi: 10.1016/j.redox.2017.02.007

Fig. 3.

Fig. 3

MF-CS study experimental plan and safety profile. Panel A illustrates the experimental design of the in vivo study evaluating protective effect of MF against CS- induced cerebrovascular impairment. Panel B: Effect of saline/MF treatments with / without CS exposure on body weight and fasting glucose levels in vivo. N=4 to 6 mice per group, p<0.05 week 4 vs day 0.